{
  "catalogId": "5a7bfc4d-a974-4bba-a28b-86a3c3a03d41",
  "name": "SATIVEX",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "147 48 33290 00",
  "treatmentDescriptions": "Sativex is indicated, as add-on treatment, for symptom relief in patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other medication and who demonstrate at least 20 % improvement in spasticity related symptoms during a four week trial of therapy.",
  "termsOfIssue": "Prescription required",
  "form": "oromucosal spray",
  "route": "oral transmucosal",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "CANNABIDIOL DRUG SUBSTANCE ( CBD BDS )/, DELTA-9-TETRAHYDROCANNABINOL DRUG SUBSTANCE  ( THC BDS )/",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "N02BG10",
      "name": "NABIXIMOLS"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "SATIVEX 3X10ML OROMUCOSAL SPRAY",
      "manufacturer": {
        "name": "ניאופרם",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 3.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL AMBER GLASS TYPE I",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "7230",
        "yarpa": "31035",
        "pharmasoft": "19970"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 1315.250546,
        "retailMargin": 17.5,
        "maxRetailPrice": 1545.419391,
        "maxPriceWithVAT": 1823.594801
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T08:01:11.338518"
  }
}